56 F
New York
Friday, November 27, 2020

The Forecast Just Changed on Artelo Biosciences Inc. (NASDAQ:ARTL)

Must read

MPLX LP (NYSE:MPLX) is Waving the Bear Flag

MPLX LP (MPLX) shares are trading at lower $22.27 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Titan Medical Inc. (NASDAQ:TMDI) Recent Earnings Shows Major Promise

Titan Medical Inc. (TMDI) shares are trading at higher $0.99. To add more color to this target, the company’s high over the last year...

The Home Depot Inc. (NYSE:HD) Stock is Soaring, Here is Why

The Home Depot Inc. (HD) shares are trading at higher $273.96 and the avg recommendation for the stock is Moderate Buy, while the current...

Chewy Inc. (NYSE:CHWY) is Gaining Momentum on Earnings Catalyst

Chewy Inc. (CHWY) shares are trading at higher $69.34 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Artelo Biosciences Inc. (ARTL) shares are trading at lower $0.58 and the avg recommendation for the stock is Hold.

To add more color to this target, the company’s high over the last year is $4.42 and the low is $0.59. Over the last 52 weeks, ARTL is down -75.21% while the S&P 500 is up 14.62%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

ARTL Return on Equity (ROE) is -103.10%, and its Return on Assets is -90.90%. All told, it is clear that, ARTL needs to be on your watchlist.

Find out when ARTL reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ARTL has a short ratio of 0.12 and outstanding shares of 3.47M.

Company Outlook

ARTL has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 2.39 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.35. Artelo Biosciences Inc. ARTL also noted assets of $3.49 million at the end of the last quarter. Investors should also keep an eye on sector updates as ARTL has historically followed its peers on positive news.

All told, Artelo Biosciences Inc. ARTL has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ARTL represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Artelo Biosciences Inc. ARTL is now commanding a market cap of 9.24M and a float of 3.35M. ARTL is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ARTL stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in ARTL, either long or short, and we have not been compensated for this article.

Latest article

Juniper Networks Inc. (NYSE:JNPR) Stock is Plummeting, Here is Why

Juniper Networks Inc. (JNPR) shares are trading at lower $22.04 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Chindata Group Holdings Limited (CD)’s Stock is Jumping, Here is Why

Chindata Group Holdings Limited (CD) shares are trading at higher $18.94. To add more color to this target, the company’s high over the last...

Can We Expect More Volatility From BOQI International Medical Inc. (BIMI)?

BOQI International Medical Inc. (BIMI) shares are trading at higher $2.09. To add more color to this target, the company’s high over the last...

When Will Diffusion Pharmaceuticals Inc. (DFFN) Slow Down

Diffusion Pharmaceuticals Inc. (DFFN) shares are trading at higher $0.78. To add more color to this target, the company’s high over the last year...

EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) is Gaining Momentum on Earnings Catalyst

EyePoint Pharmaceuticals Inc. (EYPT) shares are trading at higher $0.47 and the avg recommendation for the stock is Moderate Buy. To add more color...